All News
Feature article - The hidden cost of running the same experiment twice
Andrew Warmington
WuXi AppTec fights ‘Chinese military company’ designation
Andrew Warmington
Axplora consolidates UDCA manufacture
Andrew Warmington
Activist shareholder targets Ashland
Andrew Warmington
ECHA establishes alternative testing platform
Andrew Warmington
Chemservice buys EBRC
Andrew Warmington
CBE JU announces annual grants
Andrew Warmington
Givaudan takes control at Eurofragance
Andrew Warmington
UPM in IP deal
Andrew Warmington
CordenPharma buys AmbioPharm
Andrew Warmington
Evonik in mining chemical partnership
Andrew Warmington